Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,760,383 papers from all fields of science
Search
Sign In
Create Free Account
Revlimid
Known as:
Celgene brand of lenalidomide
, Revimid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
lenalidomide
lenalidomide 15 MG Oral Capsule [Revlimid]
lenalidomide 25 MG Oral Capsule [Revlimid]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Induction therapy for patients eligible for HDT – ASCT
Ş. Bakanay
,
M. Beksaç
2017
Corpus ID: 4508932
2017
2017
Revlimid (Lenalidomide) Receives New Indication for Multiple Myeloma as Maintenance Therapy After Transplantation
Lisa A. Raedler
,
Rph
,
M. Writer
2017
Corpus ID: 80106589
Multiple myeloma is a cancer of plasma cells in the bone marrow that often leads to bone destruction and bone marrow failure.1,2…
Expand
2016
2016
Combination therapy with lenalidomide and dexamethasone for multiple myeloma : a meta-analysis of phase III randomized controlled trials
Yuan-Yuan Kong
,
Liang-Ning Hu
,
+8 authors
Jumei Shi
2016
Corpus ID: 53608347
Novel oral immunomodulatory drug lenalidomide has been proven to have significant clinical activity in multiple myeloma (MM…
Expand
2014
2014
Revlimid (Lenalidomide) Receives a New Indication for the Treatment of Patients with Relapsed or Progressing Mantle-Cell Lymphoma
Lisa A. Raedler
,
Rph
2014
Corpus ID: 73016859
Review
2013
Review
2013
Chapter 7 Induction Therapy in Multiple Myeloma
Ş. Bakanay
,
M. Beksaç
2013
Corpus ID: 43489602
Today, multiple myeloma (MM) can be defined as a heterogenous disease composed of different clinical conditions. The differences…
Expand
2013
2013
Database study of lenalidomide (Revlimid) in Germany: monitoring off-label use [Monitoring des Off-Label-Use von Lenalidomid (Revlimid) in Deutschland]
M. Dörks
,
I. Langner
,
S. Behr
,
A. Timmer
,
E. Garbe
2013
Corpus ID: 168911920
2013
2013
Revlimid Receives a New Indication for the Treatment of Patients with Relapsed or Progressing Mantle-Cell Lymphoma
Lisa A. Raedler
,
Rph
2013
Corpus ID: 79028616
2008
2008
Effect of bortezomib, cyclophosphamide, and filgrastim on complete remission rates and CD34+ stem cell collections in multiple myeloma (MM)
R. Niesvizky
,
J. Stern
,
+7 authors
M. Coleman
2008
Corpus ID: 74707770
8587 Background: Typical stem cell mobilization regimens in MM include G-CSF alone or with high-dose cyclophosphamide. Given the…
Expand
2006
2006
Lenalidomide-Induced Warm Autoimmune Hemolytic Anemia TO THEEDITOR: Cases of warm autoimmune hemolytic anemia (AIHA) due to treatment with lenalidomide (Revlimid; Celgene Cor- poration, Summit, NJ…
K. Darabi
,
Shailaja Kantamnei
,
P. Wiernik
2006
Corpus ID: 74261690
2004
2004
Traitements innovants du myélome multiple
Xavier Leleu Frédérique Kuhnovski Valérie Coiteux Louis T Facon
2004
Corpus ID: 70424460
Le myelome multiple (MM) represente environ 1 % des cancers et 10‐12 % des hemopathies malignes. La mediane d’âge au diagnostic…
Expand